Issued Vaccine Lots

FDA Lot-Release Authorizations

These memos show the authority for the manufacturer to release anthrax vaccine from the manufacturing plant. Each lot of every vaccine produced in the United States must be individually released in this way, after having been tested for sterility, purity, potency, and general safety. Lot-release tests are performed by the manufacturer and audited by FDA. View Pre-Renovation Lots
select
FAV111 PDF 17 Mar 05
FAV114 PDF 17 Mar 05
FAV113 PDF 22 Feb 05
FAV112 PDF 15 Feb 05
FAV109 PDF 30 Dec 04
FAV110 PDF 30 Dec 04
FAV107 PDF 27 Dec 04
FAV108 PDF 21 Dec 04
FAV105 PDF 08 Dec 04
FAV106 PDF 08 Dec 04
FAV099 PDF 14 Oct 04
FAV103 PDF 30 Sep 04
FAV104 PDF 30 Sep 04
FAV102 PDF 10 Aug 04
FAV101 PDF 10 Aug 04